DUBLIN, May 17, 2023 /PRNewswire/ — The “Genetic Toxicology Testing Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F Segmented by Component (Reagents & Consumables, Assays, Services), By Type (In Vitro v/s In Vivo), By Application, By Region” report has been added to ResearchAndMarkets.com’s offering. Global genetic toxicology testing market is anticipated to witness impressive … Read more
NEW YORK, May 17, 2023 /PRNewswire/ — In a robust demonstration of support for academic freedom and open debate, FAIR in Medicine and a group of over 1,800 signatories have signed an open letter advocating for the uninterrupted publication of “Rapid Onset Gender Dysphoria: Parent Reports on 1655 Possible Cases” by Diaz and Bailey in the … Read more
DUBLIN, May 17, 2023 /PRNewswire/ — The “Early Toxicity Testing Market by Technique, by Toxicity Endpoint, by End User – Global Opportunity Analysis and Industry Forecast, 2023-2030” report has been added to ResearchAndMarkets.com’s offering. The Early Toxicity Testing (ETT) Market size was valued at USD 8.92 billion in 2022, and is predicted to reach USD 14.39 … Read more
DUBLIN, May 17, 2023 /PRNewswire/ — The “Surgical Procedures Market by Surgery Type – Global Opportunity Analysis and Industry Forecast, 2023-2030” report has been added to ResearchAndMarkets.com’s offering. The Surgical Procedures Market size was 294,237 thousand units in 2022, and is predicted to reach 372,837 thousand units by 2030, with a CAGR of 3.1% from 2023 … Read more
Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning among key areas of investment for pharma LONDON, May 17, 2023 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its new report, Biopharma Dealmaking in 2023. This year’s report … Read more
Cell therapy, RNA technology, antibody drug conjugates and AI/machine learning among key areas of investment for pharma LONDON, May 17, 2023 /PRNewswire/ — Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today released its new report, Biopharma Dealmaking in 2023. This year’s report … Read more
Stockholm, May 17, 2023 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today announced the publication of results from a simulation study evaluating the societal value of lecanemab (brand name in the U.S.: LEQEMBI™), an investigational anti-amyloid beta (Aβ) protofibril[1] antibody, for the treatment of early Alzheimer’s disease[2], in the context of the … Read more